BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 227980)

  • 1. Synthetic phospholipid vesicles containing a purified viral antigen and cell membrane proteins stimulate the development of cytotoxic T lymphocytes.
    Loh D; Ross AH; Hale AH; Baltimore D; Eisen HN
    J Exp Med; 1979 Nov; 150(5):1067-74. PubMed ID: 227980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L.
    Ciavarra R; Forman J
    J Exp Med; 1982 Sep; 156(3):778-90. PubMed ID: 6286837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles.
    Ruebush MJ; Hale AH; Harris DT
    Infect Immun; 1981 May; 32(2):513-7. PubMed ID: 6265359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.
    Bowman MR; Lyles DS; Parce JW
    J Virol; 1987 Jun; 61(6):1992-8. PubMed ID: 3033326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes.
    Hale AH; Witte ON; Baltimore D; Eisen HN
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):970-4. PubMed ID: 204941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
    Forman J; Goodenow RS; Hood L; Ciavarra R
    J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
    Lawman MJ; Naylor PT; Huang L; Courtney RJ; Rouse BT
    J Immunol; 1981 Jan; 126(1):304-8. PubMed ID: 6969745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.
    Hale AH; Ruebush MJ; Lefrançois L
    Eur J Immunol; 1981 May; 11(5):434-6. PubMed ID: 6266837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and unidirectional membrane redistribution of an H-2 antigen with an antibody-clustered viral antigen: relationship to mechanisms of cytotoxic T-cell interactions.
    Geiger B; Rosenthal KL; Klein J; Zinkernagel RM; Singer SJ
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4603-7. PubMed ID: 228303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
    Sheil JM; Bevan MJ; Lefrancois L
    J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins.
    Finberg R; Mescher M; Burakoff SJ
    J Exp Med; 1978 Dec; 148(6):1620-7. PubMed ID: 214512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.
    Roscoe DM; Ishikawa K; Lyles DS
    J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes.
    Hale AH; Lyles DS; Fan DP
    J Immunol; 1980 Feb; 124(2):724-31. PubMed ID: 6243330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.
    Rosenthal KL; Zinkernagel RM
    J Immunol; 1981 Feb; 126(2):446-51. PubMed ID: 6256440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection.
    Petrarca MA; Reiss CS; Diamond DC; Boni J; Burakoff SJ; Faller DV
    Microb Pathog; 1988 Nov; 5(5):319-32. PubMed ID: 2853279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.